Latest Schedule 13D activist filings

GE Aerospace has significantly increased its investment in BETA Technologies, Inc., acquiring a 9.2% beneficial ownership stake through a combination of preferred stock conversion, warrant issuance, and an IPO purchase.

An amendment to Schedule 13D confirms the Thomson family's continued majority beneficial ownership in Thomson Reuters Corporation, with recent internal share transfers and pledges disclosed.

Tony L. Alford, a director of Lion Copper & Gold Corp., increased his beneficial ownership to 46.36% through a $1.4 million convertible debenture purchase and open market acquisitions.

Toro Corp.'s CEO, Petros Panagiotidis, and Pani Corp. reported an increase in their beneficial ownership to 59.2% following a new grant of 2.34 million restricted shares.

Doma Perpetual Capital Management, holding a 6.8% stake in Pacira BioSciences, is demanding the company immediately hire bankers to explore a sale, citing management underperformance and excessive spending.

An amendment to Schedule 13D details the beneficial ownership of ImmunityBio, Inc. common stock by Patrick Soon-Shiong and affiliated entities, with Dr. Soon-Shiong's aggregate stake reaching 68.9%.

Saba Capital Management and affiliates have increased their beneficial ownership in Ellsworth Growth and Income Fund Ltd. to 12.29% through recent open market purchases.

Saba Capital Management, L.P. has reduced its beneficial ownership in MFS High Income Municipal Trust to 6.09% through a series of open market sales.

Saba Capital Management, L.P. and its affiliates reported a reduction in their beneficial ownership of Nuveen Pennsylvania Quality Municipal Income Fund common shares to 11.45% through recent open market sales.

Saba Capital Management and affiliates updated their beneficial ownership in Japan Smaller Capitalization Fund, Inc., reporting a 6.27% stake and recent share sales.

JANA Partners Management, LP, a significant shareholder, has updated its beneficial ownership in Mercury Systems Inc. to 8.3% following a recent share sale and DSU grants.

Patrick Dugan and the Estate of Lydia Dugan have filed an exit Schedule 13D, reporting the sale of over 2.3 million shares of United States Antimony Corporation stock and ceasing to be a beneficial owner of more than 5%.

Fluor Corporation has converted its Class B shares in NuScale Power Corp. to Class A common stock and initiated a sale program for 71 million shares, while also amending a tax agreement.

Fluor Corporation has converted its Class B shares in NuScale Power Corp. to Class A common stock and initiated a sale program for 71 million shares, while also amending a tax agreement.

BVF Partners and affiliates report a revised 27.7% beneficial ownership in MoonLake Immunotherapeutics following an increase in outstanding shares.

A group of investors led by Gefen Capital Investments has significantly increased its beneficial ownership in Steakholder Foods Ltd. to 19.8%-20.9% and appointed two new directors to the board following strategic investments and the acquisition of Twine Solutions Ltd.

New Enterprise Associates 17 and its affiliates have reported a decrease in their beneficial ownership of MBX Biosciences, Inc. common stock to 8.1% due to an increase in outstanding shares.

Perceptive Advisors and its affiliates have significantly reduced their beneficial ownership in Lyra Therapeutics, Inc. to 11.2% through recent share sales.

Katapult Holdings, Inc. received a $65 million investment from HHCF Series 21 Sub, LLC, involving convertible preferred stock and warrants, alongside significant board changes.

Versant Venture Capital funds have reported a material decrease in their aggregate beneficial ownership of LENZ Therapeutics, Inc. common stock, driven by share sales and dilution.

Gate City Capital Management and Michael Melby have increased their beneficial ownership in Intrepid Potash Inc. to 5.22% of outstanding common stock.

Ligand Pharmaceuticals has increased its beneficial ownership in Pelthos Therapeutics to 49.9% through a new $9.0 million senior secured convertible note financing.

Pelthos Therapeutics Inc. has secured a $9.0 million Senior Secured Convertible Note from Ligand Pharmaceuticals Incorporated, enhancing its financial position and granting Ligand significant royalty interests.

RA Capital Management and its affiliates reported a dilution of their beneficial ownership in Cidara Therapeutics, Inc. to 10.7% due to new share issuances by the company.

Tether Holdings and its affiliates filed an amended Schedule 13D for Bitdeer Technologies Group, reporting an 18.1% stake and disclosing recent open market share sales.

PEDEVCO Corp. announced the completion of significant mergers and a $35 million PIPE financing, alongside Dr. Simon Kukes' resignation from the board.

Arts Wing Limited and Robert Liu have disclosed a 28.80% beneficial ownership stake in Maase Inc. following an acquisition transaction.

Morgan Lee Lekstrom, Chairman of Streamex Corp., has disclosed a 13.99% beneficial ownership stake in the company following a share exchange related to the acquisition of Streamex.

Karl Henry Michael McPhie, co-founder of Streamex, becomes CEO of Streamex Corp. and discloses beneficial ownership of 14.2% of common stock following a share exchange.

Major shareholders, including Piton Capital Partners and director Robert Averick, have signed a voting agreement to support Gulf Island Fabrication's merger with IES Holdings.